Introduction
The question as to whether a nosological subgroup characterized by abnormal bodily sensations can be identi®ed within the symptomatically heterogeneous`group of schizophrenias' has been discussed ever since Bleuler (1) introduced the term schizophrenia into the literature. Most notably, Huber (2±4) described a subtype called`cenesthetic schizophrenia', and the term`cenesthopathic schizophrenia' is included within the category`other schizophrenia' (F20.8) in ICD-10 classi®cation (5). Diagnostic Statistical Manual (DSM)-IV (6) does not have a similar diagnostic category. In clinical practice, this diagnosis is rarely made, and the de®ning characteristics as well as its clinical relevance remain unclear. It appears that the majority of patients with marked bodily sensations are currently diagnosed as suering from paranoid schizophrenia, possibly because these phenomena are generally classi®ed as somatic hallucinations or delusional perception.
A wide range of inconsistent concepts and umbrella terms has been used in the literature to describe the corresponding phenomenology (7) . The term cenesthesia is mainly applied in the German (`CoenaÈ sthesie, GemeingefuÈ hl'), French (`sensibilite generale, cenesthesie') and Russian (`cenesthopathies') literature, whilst the anglophone literature mainly refers to the term`body image aberration' in summarizing abnormal bodily sensations. Their relationship to each other and their association with nuclear psychopathology as well as their relevance for the de®nition of the cenesthopathic subtype have not been investigated so far and the concepts have overlapping connotations. Theoretically, disturbances of ego-consciousness, ego-disintegration in particular, have been assigned signi®cance in generating abnormal bodily sensations (8, 9) .
To investigate the classi®cation of schizophrenic patients into distinct groups, cluster analysis with subsequent examination of dierences in clinical characteristics has been repeatedly suggested as the statistical method to achieve this (10, 11) .
In this study, we hence assessed cenesthesias and dierent aspects of body image aberration along with common and ego-psychopathology in a Objective: To identify and characterize a subgroup of schizophrenia patients with marked and dominating bodily sensations (cenesthesias and body image aberration). Method: We assessed cenesthesias and dierent aspects of body image aberration systematically along with common (general, positive and negative symptoms) and ego-psychopathology in 60 patients with acute paranoid schizophrenia. Cluster analysis was applied to identify subgroups. Psychopathology scores of the clusters were compared at admission and after 2 weeks of hospital treatment. Results: One of the three clusters comprised of 14 patients (23.3%) with marked disturbances of body experience (underestimation of lower extremities, desomatization, boundary loss and diminution). The subgroup was further characterized by signi®cantly higher egopsychopathology scores at admission. Some of the dierences held true over a 2-week period.
Conclusion:
The ®ndings from the present study suggest that cenesthesias and body image aberration might represent an additional dimension of psychopathology that might be used for de®ning a nosological subtype of schizophrenia.
sample of patients with acute paranoid schizophrenia, aiming to identify a subgroup and its characteristics.
Material and methods
The study group consisted of consecutively admitted patients to a psychiatric hospital with catchment area responsibility in Berlin, Germany. Patients between 18 and 60 years of age and suering from paranoid schizophrenia were included. Diagnosis was initially made by the psychiatrist-in-charge according to DSM-IV, and was later con®rmed by a research psychiatrist. Patients with a history of a serious physical illness, physical disability or substance abuse/dependency were excluded. All subjects gave informed consent. The sample was restricted towards this subtype in order to assess a homogenous group of patients with predominantly positive symptoms. Patients were assessed within 3 days of admission, the follow-up assessment was carried out after 2 weeks. The interviewer, a research psychiatrist, was not involved in treatment. Basic sociodemographic and clinical data and details of psychiatric history were obtained from the patient or from their medical records (sex, age, body mass index, marital and employment status, accommodation, educational background, duration of illness and number of previous hospitalizations).
Various aspects of body experience were assessed, representing cenesthesias as well as cognitive, aective and perceptual facets of body image pathology. The latter were chosen because they have been found to speci®cally occur in patients with paranoid schizophrenia in previous studies (12±14).
The following instruments were applied: 1. Bonn Scale for Assessment of Basic Symptoms/ Category D`Cenesthesias' [BSABS; 16 items (15), see Table 1 ]. The scale was developed in collaboration with Huber and follows his concept of cenesthesias as basic symptoms of schizophrenia. KlosterkoÈ tter et al. (16, 17) re-validated the subsyndrome`cenesthesias' through a multivariate cluster analysis of the BSABS. 2. The modi®ed Image-Marking Procedure (IMP) (12, 18, 19) was used for recording segmental body size perception of lower extremities (four distances, united to a segment called`Legs'). Patients marked distances as estimated in response to a two-point tactile stimulus by the investigator (using a beam bender similar to an instrument called an`anthropometer' in order to avoid the psychological impact of direct body-to-body contact). Body perception indices (BPI) were calculated according to the established formula: perceived size/real size´100 (20) . Priebe and RoÈ hricht (14) recently described psychometric properties of this instrument, indicating good internal consistency: Cronbach's a for the four measures of BPI`legs' (thigh and calf each frontal and sagittal) was 0.84, for the two measures of BPI`head' (frontal and sagittal) 0.51, and for the four items forming BPI`trunk' (shoulder/waist/hips/abdomen) 0.78. The retestreliability was 0.75 for BPI`legs', 0.75 for BPÌ head' and 0.84 for BPI`trunk'. 3. Body cathexis (`How satis®ed are you with your body?') was self-rated on a 10-cm long Visual Analogue Scale (extreme points: 0 totally satis®ed, 10 totally dissatis®ed). Each 1 cm is marked so that the scale combines qualities of a Visual Analogue-Scale (VAS) with features of an 11-point rating scale in order to increase accuracy and consistency of ratings (21, 22). 4. The same type of scale was applied to assess aspects of body concept called`small' (feeling as if the body or its parts is/are unusually small),`large' (feeling as if the body or its parts is/are unusually large) and`alteration of body size' (feeling as if the body size has changed). Each item had the extreme scores 0 (absolutely right) and 10 (absolutely wrong). 5. Two other aspects of body concept were assessed using subscales of the Body Distortion Questionnaire (BDQ;`boundary loss' and`depersonalization' with 10 items each) (23); the`depersonalization' subscale refers only to body related items and therefore represents desomatization. Psychopathology was assessed on the following scales:
1. Positive and Negative Symptom Scale (PANSS) (24). 2. Ego-Psychopathological Interview Schedule (EPP) (9) . This instrument was developed and empirically validated by Scharfetter (®rst published in 1981) on the basis of his phenomenological concept of ego-consciousness. The EPP consists of 53 items, covering ®ve basic dimensions of ego/selfawareness (`identity',`demarcation',`consistency/ coherence',`activity' and`vitality'). It also includes additional factors called`overcompensation', body',`thought process' and`psychomotor behaviour'. Following a structured interview, ratings are given on single items (present/not present) as well as with respect to the ®ve subscores/dimensions (scores between 0 and 5, graduation depending on severity and intensity).
Antipsychotic medication was recorded in chlorpromazine equivalents, calculated according to Kane (25) . Adverse eects of medication were documented as reported by the patient subjectively and were assessed using the Extrapyramidal Rating Scale (EPRS) (26) .
Statistical analysis
Iterative k-means cluster analysis was used to identify subgroups with cenesthesias and facets of body image aberration as cluster criteria and con®rmed by discriminant analysis. Examining the association between cenesthesias, body image aberration and other psychopathology, Pearson correlation coecients were calculated. Identi®ed clusters were compared regarding clinical variables at admission and after 2 weeks treatment, applying non-parametric statistical procedures (Mann± Whitney) because of the small sample size. The analysis was carried out using SPSS for Windows Version 8.0. Throughout the study we used P<0.05 as the level of signi®cance (two-tailed).
Results

Demographic and clinical characteristics
At the time of initial assessment the sample consisted of n 60 patients (36 female, 24 male) with a mean age of 35.9 years (SD 11.1) and a mean body mass index of 23.7 (SD 4.6); the patients mean duration of illness was 6.0 years (SD 6.3) with a mean frequency of 3.8 previous hospitalizations (SD 3.3). All patients were treated with antipsychotics: mean chlorpromazine equivalent at admission 487.0 mg (SD 457.5) and they displayed few extrapyramidal side-eects as measured with the EPRS (mean 0.20, SD 0.25).
A total of 43 patients were re-assessed after 2 weeks in-patient treatment, the remaining 17 patients were already discharged or refused follow-up assessment.
Out of the total sample two main cluster subgroups were identi®ed, consisting of n 14 with and n 42 without marked abnormal bodily sensations respectively, n 12/30 after 2 weeks (how we derived the clusters and their signi®cance will be fully explained further down); the subgroups were comparable regarding these demographic and clinical characteristics.
Assessing psychopathological symptoms through the Positive and Negative Symptom Scale/PANSS and the EPP, the following scores were obtained (at admission/after 2 weeks): PANSS-general: mean 39.0/32.6, SD 8. Cenesthesias and body image aberration Table 1 summarizes cenesthesias as assessed on the BSABS. The most frequent bodily sensations reported include`numbness; stiness',`desomatization',`abnormal pain',`emptiness, heaviness, lightness, falling/sinking, levitation/elevation' and diminution, shrinking, enlargement, constriction', each rated by more than 25% of the sample.
Mean scores of body image aberration of the whole sample at admission and after 2 weeks are presented in Tables 2 and 3 . They indicate a tendency to underestimate lower extremities and moderate disturbances of body concept (including symptoms of desomatization and boundary loss as well as, to a lesser degree, feelings of body size change). Body cathexis was positive.
The above symptoms did not show any signi®-cant association (Pearson's r or t-tests) with demographic (age, sex, body mass index) and clinical characteristics (number of previous hospitalizations, duration of illness, dosages of neuroleptic medication in chlorpromazine equivalents and extrapyramidal side-eects). With regard to psychopathological symptoms, a negative association between underestimation of lower extremities and anxiety (PANSS-anxiety: r ±0.28, P < 0.05) was found as hypothesized, consistent with ®nd- ings of a previous study (12, 27) . VAS`large' was positively correlated with PANSS-scores`general' and`positive' as well as item-scores`delusions', grandiosity',`unusual thought content',`mannerism' (r 0.26±0.56, P < 0.05 to < 0.001) and negatively correlated with`Depression' (r ±0.36, P < 0.01). No other result reached statistical signi®cance. Cenesthesias were found to be positively correlated with disturbances of body concept, i.e. boundary loss (r 0.45), desomatization (r 0.46), feeling as if the body or its parts feel unusually small (r 0.45) and unusually large (r 0.52) and as if the size of the body has changed (r 0.42). They were also positively associated with the EPP-factor`body' (r 0.64; each P < 0.01), but not with disturbances of body size perception (underestimation of lower extremities) and body cathexis.
Subgroup-identification/cluster descriptions
On the basis of variables representing disturbed body experience in paranoid schizophrenia (BPIlegs, EPP-body, BSABS cenesthesias, BDQ depersonalization and BDQ boundary loss, VAS-small, VAS-large, VAS-body size change, VAS-body cathexis), k-means cluster analysis was conducted. The majority of the sample (42 patients) scored in cluster one. The cluster centre shows only slight disturbances on boundary loss/desomatization (BDQ) and cenesthesias (BSABS) scales, and no disturbance on body size perception. The second cluster comprises of only four clients, mainly characterized by very high scores on BPI legs, indicating remarkable overestimation of lower extremities. The third cluster (14 patients) represents a sample of patients with marked disturbances of body experience, i.e. moderate cenesthesias scores and high boundary loss/desomatization scores, marked underestimation of lower extremities (BPI scores < 100) and high scores on VAS-scales (particularly`small' and body size change'). A con®rmatory discriminant analysis correctly classi®ed 93% of cases. Findings are summarized in Table 2 .
At follow-up after 2 weeks (Table 3 ) the subgroups consisted of n 30/1/12 patients. The disturbances of body experience within the third subgroup as well as the dierences between the two major subgroups were consistent, but only the dierence on BPI score reached statistical signi®cance. Clinical characteristics of the cluster-subgroup with body image aberration
The second cluster subgroup (n 4/1) was not considered for further statistical analysis because of its small size. There were no signi®cant dierences between the two remaining groups with respect to all demographic and clinical data, including cognitive disturbances as measured through the PANSS scale.
Comparing the two main subgroups, no signi®-cant dierences in PANSS-scores could be detected (Z between ±0.1 and ±1.1), whereas the subgroups diered with regard to EPP scores`vitality' (Z ±2.3, P 0.021),`identity' (Z ±2.2, P 0.027),`demarcation' (Z ±3.2, P 0.002) and the total score (Z ±3.1, P 0.002) at admission, indicating a higher degree of psychopathology in these areas. When re-assessed after 2 weeks, the initially identi®ed subgroup with marked body image aberration still displayed a signi®cantly higher score for the subscale`identity' (Z ±2.6, P 0.010) and with a tendency towards signi®-cance for the total EPP score (Z ±1.8, P 0.071). No other dierence reached statistical signi®cance because they had reduced and because of the smaller sample size (n 30 vs. n 12).
Discussion
This is the ®rst study to have comprehensively examined cenesthesias and body image aberration along with common psychopathology in a sample of paranoid schizophrenia patients. Hereby, a proposed subgroup of schizophrenia patients with abnormal bodily sensations has been empirically identi®ed through cluster analysis. Results from con®rmatory discriminant analysis and observed cluster dierences on ego-psychopathology indicate face-validity of the clusters derived. Despite methodological limitations of the study such as the small sample size and the restriction to paranoid schizophrenia, the results may be interpreted in at least two dierent ways.
First, the results support the repeatedly made observation of a close relationship between cognitive-or ego-disintegration and disturbances of body experience (8, 9, 28, 29) . The phenomenological concept of ego-psychopathology has so far received little attention, although several psychiatrists since Heinroth (30) described schizophrenia as a severe ego-disorder. Accordingly, Schneider (31) described delusional perception as well as somatic and other passivity experiences as ®rst-rank symptoms of schizophrenia, also referred to as a loss of`Meinhaftigkeit' (belonging to myself).
The simultaneous nature of disturbances of egodemarcation and body-boundary loss within our sample suggests that these phenomena comply with or represent each other.
Secondly, the ®ndings of the present study are in line with results of other cluster and factor analytic studies, trying to identify symptom dimensions in schizophrenia and concluding that the negative± positive dichotomy in schizophrenia appears to be of questionable validity and hence an oversimpli®cation (e.g. 10, 32, 33) . The reported cluster is probably close to a cluster subgroup described by Carpenter et al. (34) and called`hypochondriacal schizophrenia' with high ratings on somatic concerns. The results may, therefore, be interpreted in the context of consistent theoretical considerations in literature, suggesting a nosological subtype of schizophrenia with dominating abnormal bodily sensations, termed as`hypochondriac paraphrenia' (35) or`hypochondriac hebephrenia' (36) . Later on, Leonhard (37) described`systematic hypochondriacal paraphrenia' as a subform of paranoid schizophrenia. Huber (2, 3) eventually introduced a subtype called`cenesthethic schizophrenia', mainly characterized by dominating abnormal bodily sensations/feelings and with hypochondriac leanings. Within his unsystematic collection of psychopathological phenomena, Huber did not distinguish between dierent facets of body experience. Prevalence data on this subtype from the very few studies available vary between 6.25% (38) and 18% (2) of schizophrenia patients. The inconsistency of symptom de®nitions, inclusion criteria and methodological approaches makes a comparison of these publications dicult.
The syndrome characterizing the subgroup identi®ed in this study appears to be dierent from Huber's concept of cenesthetic schizophrenia, although there might be a considerable overlap. Huber (3, 4) focussed on a group of patients with hypochondriacal prodromal symptoms or unspeci®c somatic complaints prior to the onset of schizophrenia with dominating cenesthesias. Our study aimed instead at a complex assessment of a range of abnormal bodily sensations in acute patients, using de®ned and distinct categories. As a result, patients in the identi®ed cluster subgroup did display higher scores on cenesthesias, but the dierence was not statistically signi®cant, whereas distorted body size perception and disturbances of body concept clearly dierentiated between groups. Assessing the relationship of dierent categories of abnormal bodily sensations, cenesthesias were found to be signi®cantly positively related with disturbances of body concept. This suggests classi®cation of these phenomena as delusional perception rather than perceptual aberration, i.e. misinterpretation of internal perception. Huber (2, 4) focussed his aetiological hypotheses on the limbic system and the diencephalon due to phenomenological analogies with spontaneous sensations of the thalamus and symptoms related to organic neural dysfunction of these areas. Alternatively, our phenomenological ®ndings warrant a dierent explanatory model, considering a de®cit in integrating various visual and somatosensory inputs into one stable central nervous representation. Leonhard (39) discussed a theory that`bodily processes otherwise not accessible for the conscious thinking penetrate into the consciousness'. This could result in a variety of misperceptions (e.g. cenesthesias) or speci®c somatic agnosia (e.g. underestimation of lower extremities), suggesting a central pathogenic role of parietal structures.
Clinical implications of identifying a subgroup with marked body related symptomatology remain to be explored in further longitudinal studies. Abnormal bodily sensations are also represented within the concept of`basic symptoms' which has recently received increased attention. Basic symptoms have been found to be early predictors for developing schizophrenia (e.g. 16, 40, 41) . Other potential clinical implications that might warrant further studies are a speci®c response to dierent neuroleptics including body-related side-eects. The association between ego-psychopathology and disturbances of body experience might be addressed therapeutically through body-oriented intervention strategies (e.g. sensory awareness training, movement and drama therapy, dance therapy). According to Scharfetter (8, 9) this behavioural approach aims at reconstructing a realistic, coherent and integrated ego/self-experience, subsequently improving reality-testing and coping strategies.
The ®ndings require replication, and patients with subtypes other than paranoid schizophrenia have to be investigated to assess whether a similar subgroup with abnormal bodily sensations can be identi®ed across the full spectrum of subtypes. This study emphasizes that further research should go beyond mere listing of all abnormal bodily sensations and aim at systematic categorization. This may explore whether neurocognitive impairment, such as dysfunction of sensorimotor gating and/or de®cits in preattentive/attentive information processing, partly explain body-related phenomena. Disturbances of body experience may be considered as relevant phenomena for further analysis of dimensional symptom models and subsequent subtype classi®cation in schizophrenia. The ®nd-ings suggest that only a few body related characteristics are sucient for screening purposes and for identifying patients who may belong to the discussed subgroup.
